Price (delayed)
$0.3076
Market cap
$3.66M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.08
Enterprise value
$808,215
Processa Pharmaceuticals, Inc. was founded in 2017 in Hanover, Maryland, with a mission to develop products that can improve the survival and/or quality of life for patients who have a
There are no recent dividends present for PCSA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.